Bicycle Therapeutics plc Basic Shares Outstanding (Weighted Average)
Bicycle Therapeutics plc (BCYC) reported Basic Shares Outstanding (Weighted Average) of 69.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 69.80M shares, a 0.80% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 69.68M shares, a 0.70% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 69.37M shares, a 0.34% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 69.30M shares, a 0.46% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for fiscal 2025 was 69.28M shares, a 19.02% increase from fiscal 2024.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for fiscal 2024 was 58.21M shares, a 63.54% increase from fiscal 2023.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for fiscal 2023 was 35.59M shares, a 20.00% increase from fiscal 2022.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic for fiscal 2022 was 29.66M shares, a 18.35% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 69.80M shares 10-Q · filed 2026-07-30 | 69.74M shares 10-Q · filed 2026-07-30 | 69.62M shares derived: average of 3 quarters · filed 2026-07-30 | 69.54M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | 69.68M shares 10-Q · filed 2026-04-30 | 69.52M shares derived: average of 2 quarters · filed 2026-04-30 | 69.45M shares derived: average of 3 quarters · filed 2026-04-30 | 69.40M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | 69.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 69.33M shares derived: average of 2 quarters · filed 2026-03-17 | 69.31M shares derived: average of 3 quarters · filed 2026-07-30 | 69.28M shares 10-K · filed 2026-03-17 | |
| 2025-09-30 | 69.30M shares 10-Q · filed 2025-10-30 | 69.28M shares derived: average of 2 quarters · filed 2026-07-30 | 69.25M shares 10-Q · filed 2025-10-30 | 69.22M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | 69.25M shares 10-Q · filed 2026-07-30 | 69.22M shares 10-Q · filed 2026-07-30 | 69.19M shares derived: average of 3 quarters · filed 2026-07-30 | 69.14M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | 69.20M shares 10-Q · filed 2026-04-30 | 69.16M shares derived: average of 2 quarters · filed 2026-04-30 | 69.11M shares derived: average of 3 quarters · filed 2026-04-30 | 64.83M shares derived: average of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | 69.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 69.06M shares derived: average of 2 quarters · filed 2026-03-17 | 63.37M shares derived: average of 3 quarters · filed 2026-03-17 | 58.21M shares 10-K · filed 2026-03-17 | |
| 2024-09-30 | 68.99M shares 10-Q · filed 2025-10-30 | 60.49M shares derived: average of 2 quarters · filed 2025-10-30 | 54.57M shares 10-Q · filed 2025-10-30 | 51.51M shares derived: average of 4 quarters · filed 2026-03-17 | |
| 2024-06-30 | 51.99M shares 10-Q · filed 2025-08-08 | 47.28M shares 10-Q · filed 2025-08-08 | 45.68M shares derived: average of 3 quarters · filed 2026-03-17 | 44.16M shares derived: average of 4 quarters · filed 2026-03-17 | |
| 2024-03-31 | 42.56M shares 10-Q · filed 2025-05-01 | 42.53M shares derived: average of 2 quarters · filed 2026-03-17 | 41.54M shares derived: average of 3 quarters · filed 2026-03-17 | 38.71M shares derived: average of 4 quarters · filed 2026-03-17 | |
| 2023-12-31 | 42.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 41.04M shares derived: average of 2 quarters · filed 2026-03-17 | 37.42M shares derived: average of 3 quarters · filed 2026-03-17 | 35.59M shares 10-K · filed 2026-03-17 | |
| 2023-09-30 | 39.58M shares 10-Q · filed 2024-10-31 | 34.88M shares derived: average of 2 quarters · filed 2024-10-31 | 33.29M shares 10-Q · filed 2024-10-31 | 32.37M shares derived: average of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | 30.19M shares 10-Q · filed 2024-08-06 | 30.10M shares 10-Q · filed 2024-08-06 | 29.97M shares derived: average of 3 quarters · filed 2025-02-25 | 29.90M shares derived: average of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | 30.00M shares 10-Q · filed 2024-05-02 | 29.86M shares derived: average of 2 quarters · filed 2025-02-25 | 29.80M shares derived: average of 3 quarters · filed 2025-02-25 | 29.76M shares derived: average of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | 29.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 29.69M shares derived: average of 2 quarters · filed 2025-02-25 | 29.68M shares derived: average of 3 quarters · filed 2025-02-25 | 29.66M shares 10-K · filed 2025-02-25 | |
| 2022-09-30 | 29.68M shares 10-Q · filed 2023-11-02 | 29.66M shares derived: average of 2 quarters · filed 2023-11-02 | 29.64M shares 10-Q · filed 2023-11-02 | 29.50M shares derived: average of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | 29.65M shares 10-Q · filed 2023-08-03 | 29.63M shares 10-Q · filed 2023-08-03 | 29.45M shares derived: average of 3 quarters · filed 2024-02-20 | 28.35M shares derived: average of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | 29.61M shares 10-Q · filed 2023-05-04 | 29.35M shares derived: average of 2 quarters · filed 2024-02-20 | 27.91M shares derived: average of 3 quarters · filed 2024-02-20 | 26.95M shares derived: average of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | 29.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | 27.06M shares derived: average of 2 quarters · filed 2024-02-20 | 26.06M shares derived: average of 3 quarters · filed 2024-02-20 | 25.06M shares 10-K · filed 2024-02-20 | |
| 2021-09-30 | 25.04M shares 10-Q · filed 2022-11-03 | 24.55M shares derived: average of 2 quarters · filed 2022-11-03 | 23.72M shares 10-Q · filed 2022-11-03 | 23.07M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | 24.05M shares 10-Q · filed 2022-08-04 | 23.05M shares 10-Q · filed 2022-08-04 | 22.41M shares derived: average of 3 quarters · filed 2023-02-28 | 21.66M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | 22.10M shares 10-Q · filed 2022-05-05 | 24.05M shares 10-Q · filed 2021-08-05 | 21.59M shares derived: average of 2 quarters · filed 2023-02-28 | 20.87M shares derived: average of 3 quarters · filed 2023-02-28 | 20.17M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 21.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 20.25M shares derived: average of 2 quarters · filed 2023-02-28 | 19.53M shares derived: average of 3 quarters · filed 2023-02-28 | 19.15M shares 10-K · filed 2023-02-28 | |
| 2020-09-30 | 19.43M shares 10-Q · filed 2021-11-04 | 18.75M shares derived: average of 2 quarters · filed 2021-11-04 | 18.50M shares 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | 18.08M shares 10-Q · filed 2021-08-05 | 18.02M shares 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | 11.05M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |